Safety and Tolerability of c-MET Inhibitors in Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and Tolerability of c-MET Inhibitors in Cancer

Published:2019-01-16 Issue:2 Volume:42 Page:211-233
ISSN:0114-5916
Container-title:Drug Safety
language:en
Short-container-title:Drug Saf

Author:

Puccini Alberto,Marín-Ramos Nagore I.,Bergamo Francesca,Schirripa Marta,Lonardi Sara,Lenz Heinz-Josef,Loupakis Fotios,Battaglin Francesca

Funder

National Cancer Institute

Gloria Borges WunderGlo Foundation-The Wunder Project

Dhont Family Foundation

San Pedro Peninsula Cancer Guild

Daniel Butler Research Fund

Call to Cure Research Fund

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Toxicology

Link

http://link.springer.com/content/pdf/10.1007/s40264-018-0780-x.pdf

Reference131 articles.

1. Lemmon MA, Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 2010;141(7):1117–34.

2. Schmidt C, Bladt F, Goedecke S, Brinkmann V, Zschiesche W, Sharpe M, et al. Scatter factor/hepatocyte growth factor is essential for liver development. Nature. 1995;373(6516):699–702.

3. Chmielowiec J, Borowiak M, Morkel M, Stradal T, Munz B, Werner S, et al. c-Met is essential for wound healing in the skin. J Cell Biol. 2007;177(1):151–62.

4. Uehara Y, Minowa O, Mori C, Shiota K, Kuno J, Noda T, et al. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature. 1995;373(6516):702–5.

5. Boccaccio C, Comoglio PM. MET, a driver of invasive growth and cancer clonal evolution under therapeutic pressure. Curr Opin Cell Biol. 2014;31:98–105.

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of Pyrazolopyrazines as Selective, Potent, and Mutant-Active MET Inhibitors with Intracranial Efficacy;Journal of Medicinal Chemistry;2024-08-01

2. Solid Phase Synthesis, DFT Calculations, Molecular Docking, and Biological Studies of Symmetrical N₂,N₄,N₆-Trisubstituted-1,3,5-triazines;ACS Omega;2024-07-31

3. The MET Family of Receptor Tyrosine Kinases Promotes a Shift to Pro-Tumor Metabolism;Genes;2024-07-20

4. Cabozantinib Induces Isolated Hyperbilirubinemia in Renal Cell Carcinoma Patients carrying the UGT1A1*28 Polymorphism;Clinical Genitourinary Cancer;2024-07

5. Ovulation provides excessive coagulation and hepatocyte growth factor signals to cause postoperative intraabdominal adhesions;iScience;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3